We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.31%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$23B
AUM Growth
-$233M
(-1%)
Cap. Flow
-$880M
Cap. Flow
% of AUM
-3.82%
Top 10 Holdings %
Top 10 Hldgs %
33.31%
Holding
1,606
New
44
Increased
614
Reduced
449
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$63.2M |
| 2 |
Eagle Materials
EXP
|
+$56.2M |
| 3 |
Itron
ITRI
|
+$54.4M |
| 4 |
Apple
AAPL
|
+$52.6M |
| 5 |
Enphase Energy
ENPH
|
+$40.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cooper Companies
COO
|
+$82.8M |
| 2 |
NVIDIA
NVDA
|
+$76M |
| 3 |
Microsoft
MSFT
|
+$62.6M |
| 4 |
Adobe
ADBE
|
+$62.2M |
| 5 |
Jabil
JBL
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.79% |
| 2 | Healthcare | 19.28% |
| 3 | Financials | 10.14% |
| 4 | Communication Services | 9.05% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Aon
AON
$74.2B
| $15.9M | 0.07% |
54,082
-13,032
| -19% | -$3.85M |
|
252
Marriott International
MAR
$92.7B
| $15.7M | 0.07% |
65,019
+1,108
| +2% | +$266K |
|
253
US Bancorp
USB
$101B
| $15.6M | 0.07% |
394,123
-65,377
| -14% | -$2.67M |
|
254
VICI Properties
VICI
$28.9B
| $15.6M | 0.07% |
545,899
+52,644
| +11% | +$1.51M |
|
255
Biogen
BIIB
$31.1B
| $15.6M | 0.07% |
67,206
+3,146
| +5% | +$684K |
|
|
BNY
256
Bank of New York Mellon
BNY
$110B
| $15.5M | 0.07% |
258,557
+1,485
| +0.6% | +$85.9K |
|
257
Cintas
CTAS
$80.9B
| $15.5M | 0.07% |
88,324
-14,056
| -14% | -$2.4M |
|
258
W.W. Grainger
GWW
$61.6B
| $15.4M | 0.07% |
17,087
-1,618
| -9% | -$1.52M |
|
259
Corteva
CTVA
$50.3B
| $15.4M | 0.07% |
285,282
-85,373
| -23% | -$4.7M |
|
260
Extra Space Storage
EXR
$31.3B
| $15.1M | 0.07% |
96,879
+5,831
| +6% | +$850K |
|
261
Dell
DELL
$322B
| $15M | 0.07% |
109,058
-32,235
| -23% | -$4.32M |
|
262
Hewlett Packard
HPE
$81.1B
| $15M | 0.07% |
708,805
+27,059
| +4% | +$499K |
|
263
ResMed
RMD
$32.7B
| $15M | 0.07% |
78,383
+4,716
| +6% | +$957K |
|
264
Aflac
AFL
$60.6B
| $14.9M | 0.06% |
166,956
+6,294
| +4% | +$541K |
|
265
Alamo Group
ALG
$2.01B
| $14.8M | 0.06% |
85,579
+15,000
| +21% | +$2.93M |
|
|
HOLX
266
DELISTED
Hologic
HOLX
| $14.7M | 0.06% |
198,122
+21,182
| +12% | +$1.59M |
|
|
ALTM
267
DELISTED
Arcadium Lithium plc
ALTM
| $14.6M | 0.06% |
4,337,883
+143,980
| +3% | +$602K |
|
268
Keysight
KEYS
$60.9B
| $14.6M | 0.06% |
106,448
+6,854
| +7% | +$1M |
|
|
GRMN
269
Garmin
GRMN
$60.4B
| $14.5M | 0.06% |
89,169
-965
| -1% | -$152K |
|
270
Baidu
BIDU
$35.3B
| $14.5M | 0.06% |
167,817
-52,972
| -24% | -$5.32M |
|
271
D.R. Horton
DHI
$41.6B
| $14.5M | 0.06% |
102,543
-8,363
| -8% | -$1.23M |
|
272
Equity Residential
EQR
$24.7B
| $14.3M | 0.06% |
206,573
+23,966
| +13% | +$1.56M |
|
273
Moderna
MRNA
$25.5B
| $14.1M | 0.06% |
118,833
-7,388
| -6% | -$935K |
|
274
Hershey
HSY
$37.3B
| $14M | 0.06% |
76,226
+2,117
| +3% | +$410K |
|
275
JD.com
JD
$39.2B
| $14M | 0.06% |
541,052
-171,647
| -24% | -$5.04M |
|
Similar funds
VIA
Handelsbanken Fonder's Q2 2024 Portfolio in Review
As of Q2 2024, Handelsbanken Fonder held 1,606 positions worth $23B, down 1% from $23.2B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder withdrew a net $880M in Q2 2024, closing 86 positions and reducing 449 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $20.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Handelsbanken Fonder opened a new position in Kenvue worth $12.8M.
- Handelsbanken Fonder's largest Q2 2024 buy was Kenvue: 701,911 shares worth $12.8M.
- Handelsbanken Fonder added most to Vertex Pharmaceuticals in Q2 2024, an estimated $63.2M increase.
- Handelsbanken Fonder's biggest Q2 2024 reduction was Cooper Companies, cutting an estimated $82.8M.
- Handelsbanken Fonder fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $20.6M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $23B portfolio in Q2 2024.
- Handelsbanken Fonder opened 44 new positions and closed 86 in Q2 2024.
- Handelsbanken Fonder's portfolio value fell 1% quarter-over-quarter to $23B.
Based on Handelsbanken Fonder's 13F filing for Q2 2024, filed 5 Aug 2024.